Suppression of the nocturnal free fatty acid levels by bedtime cornstarch in NIDDM subjects

European Journal of Clinical Investigation

Volumn 27, Issue 2, 1997, Pages 157-163

  Axelsen, M ^a   Lonnroth P ^a   Arvidsson Lenner, R ^a   Smith, U ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

cornstarch; free fatty acids; insulin; insulin resistance; non insulin dependent diabetes mellitus

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN; STARCH;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0031053841     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.880639.x     Document Type: Article

References (34)

1. Campbell PJ, Bolli GB, Cryer PE, Gerich JE. Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. N Engl J Med 1985;312:1473-9.
2. Atiea JA, Asian SM, Owens DR, Luzio S. Early morning hyperglycaemia 'dawn phenomenon' in non-insulin dependent diabetes mellitus (NIDDM): effects of cortisol suppression by metyrapone. Diabetes-Res. 1990;14:181-5.
3. Shapiro ET, Polonsky KS, Copinschi G et al. Nocturnal elevation of glucose levels during fasting in non-insulin dependent diabetes. J Clin Endocr Metab 1991;72:444-54.
4. Golay A, Swislocki ALM, Chen Y-DI, Reaven GM. Relationhips between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals. Metabolism 1987;36: 692-6.
5. Groop LC, Bonadonna RC, Del Prato S et al. Glucose and free fatty acid metabolism in non-insulin dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 1989;84: 205-13.
6. Taskinen M-R, Same T, Helve E, Karonen S-L, Nikkilä EA. Bedtime insulin for suppression of overnight free-fatty acid, blood glucose, and glucose production in NIDDM. Diabetes 1989;38: 580-8.
7. Skowronski R, Hollenbeck CB, Varasteh BB, Chen Y-DI, Reaven GM. Regulation of non-esterified fatty acid and glycerol concentration by insulin in normal individuals and patients with type 2 diabetes. Diabetic Med 1991;8:330-3.
8. Puhakainen I, Koivisto VA, Yki-Järvinen H. Lipolysis and gluco-neogenesis from glycerol are increased in patients with non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1992;75: 789-94.
9. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992;15:318-68.
10. Campbell PJ, Mandarino LJ, Gerich JE. Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1988;37:15-21.
11. DeFronzo RA, Ferrannini E, Simson DC. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 1989;38:387-95.
12. Levine R, Fritz IB. The relation of insulin to liver metabolism. Diabetes 1956;5:209-22.
13. Prager R, Wallace P, Olefsky J M. Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects. Diabetes 1987;36:607-11.
14. Rebrin K, Steil GM, Getty L, Bergman RN. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 1995;44:1038-45.
15. Jenkins DJA, Wolever TMS, Taylor RH et al. Slow release carbohydrate improves second meal tolerance. Am J Clin Nutr 1982;35:1339-46.
16. Collier GR, Wolever TMS, Jenkins DJA. Concurrent ingestion of fat and reducion in starch content impairs carbohydrate tolerance to subsequent meals. Am J Clin Nutr 1987;45:963-9.
17. Shank ML, Del Prato S, DeFronzo RA. Bedtime insulin/daytime glipizide. Effective therapy for sulfonylurea failures in NIDDM. Diabetes 1995;44:165-72.
18. Vaag A, Skött P, Damsbo P, Gall MA, Richter EA, Beck-Nielsen H. Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1991; 88:1282-90.
19. Saloranta C, Franssila-Kallunki A, Ekstrand A, Taskinen M-R, Groop L. Modulation of hepatic glucose production by non-esterified fatty acids in type II (non-insulin-dependent) diabetes mellitus. Diabetologia 1991;34:409-15.
20. Piatti PM, Monti LC, Davis SN, Conti M, Brown MD, Pozza G, Alberti KGMM. Effects of an acute decrease in non-esterified fatty acid levels on muscle glucose utilization and forearm indirect calorimetry in lean NIDDM patients. Diabetologia 1996;39: 103-12.
21. Saloranta C, Taskinen MR, Widén. Härkönen M, Melander A, Groop L. Metabolic consequences of sustained suppression of free fatty acids by acipimox in patients with NIDDM. Diabetes 1993;42:1559-66.
22. Worm D, Henriksen JE, Vaag A, Thye-Ronn P, Melander A, Beck-Nielsen J. Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in non-insulin-dependent diabetes mellitus patients during a 3-day intensified treatment period. J Clin Endocrinol Metab 1994;78:717-21.
23. Chen YT, Cornblath M, Sidbury J. Cornstarch therapy in type 1 glycogen storage disease. N Engl J Med 1984;310:171-5.
24. Hayde M, Widhalm K. Effects of cornstarch treatment in very young children with type I glycogen storage disease. Eur J Pediatr 1990;149:630-33.
25. Ververs MTC, Rouwé C, Smit PA. Complex carbohydrates in the prevention of nocturnal hypoglycemia in diabetic children. Eur J Clin Nutr 1993;47:268-73.
26. Matthews JNS, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ 1990;300: 230-5.
27. Siegel S, Castellan NJ. Nonparametric systems for the behavioral sciences, 2nd edn. Anker J, ed. New York: McGraw-Hill, 1988.
28. Wolever TMS, Jenkins DJA, Ocana AM, Rao VA, Collier GR. Second-meal effect: low-glycemic-index foods eaten at dinner improve subsequent breakfast glycemic response. Am J Clin Nutr 1988;48:1041-7.
29. Cusi K, Cunningham GR, Comstock JP. Safety and efficacy of normalizing fasting glucose with bedtime NPH insulin alone in NIDDM. Diabetes Care 1995;18:843-51.
30. Fulcher GR, Walker M, Catalano C, Agius L, Alberti KGMM. Metabolic effects of suppression of nonesteritied fatty acid levels with acipimox in obese NIDDM subjects. Diabetes 1992;41: 1400-8.
31. Puhakainen I, Yki-Järvinen H. Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM. Diabetes 1993;42:1694-9.
32. Swislocki ALM, Chen Y-DI, Golay A, Chang M-O. Reaven GM. Insulin suppression of plasma free fatty acid concentration in normal individuals and patients with type 2 (non-insulin-dependent) diabetes. Diabetologia 1987;30:622-6.
33. Wolever TMS, Bentum-Williams A, Jenkins DJA. Physiological modulation of plasma free fatty acid concentration by diet: implications in non-diabetic subjects. Diabetes Care 1995;18: 962-70.
34. Nurjhan N, Consoli A, Gerich J. Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus. J Clin Invest 1992;89:169-75.